Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2482
Publisher
MDPI AG
Online
2020-09-02
DOI
10.3390/cancers12092482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
- (2020) Lisi Ma et al. Frontiers in Oncology
- Drug uptake-based chemoresistance in breast cancer treatment
- (2020) Helena Muley et al. BIOCHEMICAL PHARMACOLOGY
- Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
- (2020) Elizabeth Varghese et al. Cancers
- Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
- (2020) Jason R Brown et al. JCI Insight
- “Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
- (2019) Marco Fiorillo et al. Frontiers in Oncology
- TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis
- (2019) Alec N. Woosley et al. ONCOGENE
- Efficacious Dose of Metformin for Breast Cancer Therapy is Determined by Cation Transporter Expression in Tumors
- (2019) Hao Cai et al. BRITISH JOURNAL OF PHARMACOLOGY
- The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials
- (2019) J. Rahmani et al. Clinical & Translational Oncology
- A Novel Mechanism of High Dose Radiation Sensitization by Metformin
- (2019) Stephen L. Brown et al. Frontiers in Oncology
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer stigma and cancer screening attendance: a population based survey in England
- (2019) Charlotte Vrinten et al. BMC CANCER
- Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
- (2019) Claudia Christowitz et al. BMC CANCER
- Metformin in breast cancer: preclinical and clinical evidence
- (2019) Anindita De et al. CURRENT PROBLEMS IN CANCER
- Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
- (2019) Weige Tan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
- (2019) Ji-Chang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
- (2019) Maria Laura De Angelis et al. Frontiers in Oncology
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
- (2019) Loh et al. Cells
- Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
- (2019) Jiaojiao Zhou et al. Frontiers in Oncology
- Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
- (2019) De Angelis et al. Cancers
- Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy
- (2019) Samson Mathews Samuel et al. Cancers
- Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
- (2019) Sangita Sridharan et al. Frontiers in Oncology
- Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
- (2019) Snehal K. Shukla et al. Pharmaceutics
- Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
- (2019) Samson Mathews Samuel et al. Biomolecules
- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma
- (2018) Nobufumi Sekino et al. CANCER SCIENCE
- Randomized multicenter phase II trial of neoadjuvant therapy comparing weekly nab-paclitaxel followed by FEC with docetaxel followed by FEC in HER2-negative early-stage breast cancer
- (2018) Takashi Kuwayama et al. Clinical Breast Cancer
- Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
- (2018) Deli Hong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells
- (2018) Shahrzad Javidfar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
- (2018) Sen Xu et al. MOLECULAR CANCER THERAPEUTICS
- Aspirin and metformin exhibit antitumor activity in murine breast cancer
- (2018) Maoyuan Zhao et al. ONCOLOGY REPORTS
- Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles
- (2018) Vahid Shafiei-Irannejad et al. PHARMACEUTICAL RESEARCH
- Functional miRNAs in breast cancer drug resistance
- (2018) Weizi Hu et al. OncoTargets and Therapy
- Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant
- (2018) Julie Konge et al. Oncotarget
- Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells
- (2018) Yuan-Chiang Chung et al. Scientific Reports
- Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects
- (2018) Sara Baldassari et al. Scientific Reports
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- Challenges and perspectives in the treatment of diabetes associated breast cancer
- (2018) Samson Mathews Samuel et al. CANCER TREATMENT REVIEWS
- Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK-1-eIF4G-eIF4E signaling
- (2018) Peng Shen et al. Molecular Oncology
- Breast cancer stem cells: Features, key drivers and treatment options
- (2018) Jürgen Dittmer SEMINARS IN CANCER BIOLOGY
- The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
- (2018) Elizabeth Varghese et al. Cancers
- Novel application of metformin combined with targeted drugs on anticancer treatment
- (2018) Jun Deng et al. CANCER SCIENCE
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- Bacterial infections and cancer
- (2018) Daphne van Elsland et al. EMBO REPORTS
- Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study
- (2018) Marissa C. van Maaren et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Cancer Stem Cells to Overcome Chemoresistance
- (2018) Toni Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
- (2018) Sara R. Martins-Neves et al. PHARMACOLOGICAL RESEARCH
- Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis
- (2018) Mingyue Rao et al. Cancer Management and Research
- Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
- (2018) Arindam Banerjee et al. CARCINOGENESIS
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model
- (2017) Camila Leonel et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Transporters Involved in Metformin Pharmacokinetics and Treatment Response
- (2017) Xiaomin Liang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments
- (2017) Georg Fluegen et al. NATURE CELL BIOLOGY
- Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
- (2017) Gerald Davies et al. PLoS One
- Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells
- (2017) Feixue Feng et al. Oncology Letters
- Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel
- (2017) Yaejin Woo et al. Nutrients
- A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer
- (2017) Yannan Zhao et al. Oncotarget
- Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP
- (2017) Xuedong Wang et al. Oncotarget
- MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
- (2017) Qing Xie et al. Oncotarget
- Inhibition of FAK kinase activity preferentially targets cancer stem cells
- (2017) Vihren N. Kolev et al. Oncotarget
- Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
- (2017) Pritha Mukherjee et al. Scientific Reports
- Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
- (2017) Raana Farajzadeh et al. Artificial Cells Nanomedicine and Biotechnology
- Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
- (2017) Zong-Sheng Jiang et al. Journal of Cancer
- Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
- (2017) Pedro M. Aponte et al. Stem Cells International
- Targeting MYC Dependence by Metabolic Inhibitors in Cancer
- (2017) Himalee S. Sabnis et al. Genes
- Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
- (2017) Peiguo Shi et al. Cell Discovery
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
- (2016) C. R. Triggle et al. Acta Physiologica
- Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence
- (2016) Nicole Noren Hooten et al. AGING CELL
- Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells
- (2016) Rong Sun et al. BIOMATERIALS
- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
- (2016) D. Samanta et al. CANCER RESEARCH
- Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
- (2016) Shilpi Saha et al. CANCER RESEARCH
- Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer
- (2016) Long Chen et al. CELL CYCLE
- Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer
- (2016) Reema Wahdan-Alaswad et al. CELL CYCLE
- Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells
- (2016) Hao Cai et al. INTERNATIONAL JOURNAL OF CANCER
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity
- (2016) Yu-Feng Zou et al. Molecular Medicine Reports
- Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors
- (2016) Veronika Mamaeva et al. MOLECULAR THERAPY
- Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
- (2016) JINKYOUNG KIM et al. ONCOLOGY REPORTS
- miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7
- (2016) Wei Zhao et al. ONCOLOGY REPORTS
- Molecular targets of metformin antitumor action
- (2016) Stanisław Sośnicki et al. Pharmacological Reports
- Metformin: An anti-diabetic drug to fight cancer
- (2016) Marie Daugan et al. PHARMACOLOGICAL RESEARCH
- Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
- (2016) Sai A. Balaji et al. PLoS One
- Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance
- (2016) Fengsheng Li et al. Oncology Letters
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
- (2016) Xiewan Chen et al. Oncotarget
- PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis
- (2016) Olga Karicheva et al. Oncotarget
- Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer
- (2016) Rae-Kwon Kim et al. Oncotarget
- NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer
- (2016) Karla Vazquez-Santillan et al. Scientific Reports
- The hedgehog pathway in triple-negative breast cancer
- (2016) Joyce G. Habib et al. Cancer Medicine
- Mammary Development and Breast Cancer: A Wnt Perspective
- (2016) Qing Yu et al. Cancers
- Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44+/CD24−/low Stem Cell Phenotype
- (2016) Xuefeng Gao et al. Frontiers in Oncology
- MATE2 Expression Is Associated with Cancer Cell Response to Metformin
- (2016) Sanjana Chowdhury et al. PLoS One
- Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
- (2015) Jaslyn Sian-Siu Soo et al. APOPTOSIS
- p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells
- (2015) Puyu Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
- (2015) Rong Sun et al. BIOMATERIALS
- Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy
- (2015) Baek Kim et al. BMC CANCER
- mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
- (2015) Govindasamy-Muralidharan Karthik et al. CANCER LETTERS
- Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
- (2015) Ming Luo et al. CURRENT PHARMACEUTICAL DESIGN
- Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride
- (2015) Meltem Cetin et al. DRUG DELIVERY
- Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers
- (2015) Mette Marie Hougaard Christensen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
- (2015) CONG FAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
- (2015) Mustafa Kinaan et al. MEDICAL PRINCIPLES AND PRACTICE
- Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
- (2015) Xiaomin Liang et al. MOLECULAR PHARMACEUTICS
- Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
- (2015) Patrizia Ferroni et al. Oxidative Medicine and Cellular Longevity
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
- (2015) Deyong Jia et al. Oncotarget
- Metabolic plasticity of cancer stem cells
- (2015) Ming Luo et al. Oncotarget
- Physical Intimacy of Breast Cancer Cells with Mesenchymal Stem Cells Elicits Trastuzumab Resistance through Src Activation
- (2015) Amita Daverey et al. Scientific Reports
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Breast Cancer Recurrence According to Molecular Subtype
- (2014) Hee Jin Shim et al. Asian Pacific Journal of Cancer Prevention
- The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
- (2014) Beshay N.M. Zordoky et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
- (2014) Ji Ma et al. BMC CANCER
- PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
- (2014) V. N. Kolev et al. CANCER RESEARCH
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
- (2014) Neng Wang et al. CARCINOGENESIS
- Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
- (2014) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex
- (2014) Shumei Meng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells
- (2014) Felicia Leccia et al. Molecular Cancer
- The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
- (2014) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy
- (2014) Jennifer Sims-Mourtada et al. MOLECULAR CARCINOGENESIS
- Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined
- (2014) Hyemi Lee et al. PLoS One
- NF-κB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression
- (2014) Shannon M. Smith et al. PLoS One
- Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties
- (2014) Pegah Ghiabi et al. PLoS One
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ablation of Breast Cancer Stem Cells with Radiation
- (2014) Steven P. Zielske et al. Translational Oncology
- Human Viruses and Cancer
- (2014) Abigail Morales-Sánchez et al. Viruses-Basel
- De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling
- (2014) Catherine A. Del Vecchio et al. PLOS BIOLOGY
- Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
- (2014) Natalia Krawczyk et al. Biomed Research International
- Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
- (2014) Tae Hun Kim et al. Biomed Research International
- Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
- (2014) Reema S. Wahdan-Alaswad et al. Hormones & Cancer
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Hyperglycemia as a Risk Factor for Cancer Progression
- (2014) Tae Young Ryu et al. Diabetes & Metabolism Journal
- Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation
- (2013) Karen A Dunphy et al. Cancer Cell International
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Cancer as a metabolic disease: implications for novel therapeutics
- (2013) T. N. Seyfried et al. CARCINOGENESIS
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Treatment of Estrogen Receptor-Positive Breast Cancer
- (2013) F. Lumachi et al. CURRENT MEDICINAL CHEMISTRY
- ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel
- (2013) Jun Mao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway
- (2013) GAO YI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Curcumin Suppresses Doxorubicin-Induced Epithelial–Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells
- (2013) Wei-Chih Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition
- (2013) Shamik Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Targeting cancer stem cells to suppress acquired chemotherapy resistance
- (2013) S J Vidal et al. ONCOGENE
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells—an in vitro and in silico study
- (2013) Santhi Latha Pandrangi et al. TUMOR BIOLOGY
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Renal complications of diabetes
- (2012) T. Z. Min et al. BRITISH MEDICAL BULLETIN
- Diabetes and cancer I: risk, survival, and implications for screening
- (2012) Adedayo A. Onitilo et al. CANCER CAUSES & CONTROL
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- Metformin and Cancer Stem Cells: Old Drug, New Targets
- (2012) F. Bednar et al. Cancer Prevention Research
- Contrasting Hypoxic Effects on Breast Cancer Stem Cell Hierarchy Is Dependent on ER- Status
- (2012) H. Harrison et al. CANCER RESEARCH
- O-Carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells
- (2012) K.S. Snima et al. CARBOHYDRATE POLYMERS
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Breast cancer stem cells
- (2012) Marco A. Velasco-Velázquez et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
- (2012) Petra Hamerlik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures
- (2012) Daniel K Chan et al. Journal of Ovarian Research
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
- (2012) Chang W. Song et al. Scientific Reports
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Breast cancer subtypes and outcome after local and regional relapse
- (2011) E. Montagna et al. ANNALS OF ONCOLOGY
- Chemoresistance to 5-fluorouracil induces epithelial–mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
- (2011) Weijia Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
- (2011) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions
- (2011) Bolin Liu et al. CELL CYCLE
- Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
- (2011) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation
- (2011) Guopei Zheng et al. FEBS LETTERS
- Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
- (2011) Santhi Achuthan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation
- (2011) D. Yao et al. MOLECULAR CANCER RESEARCH
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs
- (2011) Steve Quiros et al. PLoS One
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer
- (2011) Lianhong Li Oncology Letters
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- (2010) Alejandro Vazquez-Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- The Canonical NF- B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
- (2010) M. Liu et al. CANCER RESEARCH
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Breast cancer stem cells: initiating a new sort of thinking
- (2010) J. I. Herschkowitz Disease Models & Mechanisms
- Drug delivery and nanoparticles: Applications and hazards
- (2010) de Jong International Journal of Nanomedicine
- Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis
- (2010) Guopei Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer stem cells: problems for therapy?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Down-Regulation of Rad51 Expression Overcomes Drug Resistance to Gemcitabine in Human Non-Small-Cell Lung Cancer Cells
- (2010) M.-S. Tsai et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cancer Chemotherapy: An Annotated History
- (2010) W.B. Morrison JOURNAL OF VETERINARY INTERNAL MEDICINE
- Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice
- (2010) Shuanglian Li et al. PHARMACEUTICAL RESEARCH
- Diabetes and Cancer
- (2010) T. A. Chowdhury QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb®)
- (2009) Alejandro Vázquez-Martín et al. Clinical & Translational Oncology
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework
- (2009) Bisrat G. Debeb et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function
- (2009) Ying Chen et al. PHARMACOGENOMICS JOURNAL
- Breast cancer chemoresistance: Emerging importance of cancer stem cells
- (2009) Suebwong Chuthapisith et al. SURGICAL ONCOLOGY-OXFORD
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
- (2008) E M Hurt et al. BRITISH JOURNAL OF CANCER
- Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors
- (2008) N. Shafee et al. CANCER RESEARCH
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
- (2008) Sonia Correia et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now